HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Yield of Neuroimaging in Children Presenting to the Emergency Department With Acute Ataxia in the Post-Varicella Vaccine Era.

Abstract
To determine the yield of neuroimaging in children presenting to the emergency department with acute ataxia in the post-varicella vaccine era, we conducted a cross-sectional study between 1995 and 2013 at a single pediatric tertiary care center. We included children aged 1-18 years evaluated for acute ataxia of <7 days' duration. The main outcome was clinically urgent intracranial pathology defined as a radiologic finding that changed initial management. We identified 364 children, among whom neuroimaging was obtained in 284 (78%). Forty-two children had clinically urgent intracranial pathology (13%, 95% confidence interval 9%-17%); tumors and acute disseminated encephalomyelitis were the leading findings. Age ≤3 years and symptoms ≤3 days of duration were predictors of low risk (0.7%, 95% confidence interval 0%-4.4%). In conclusion, neuroimaging may be indicated for most patients presenting with acute ataxia. Neuroimaging may be deferred in younger children with short duration of symptoms contingent on close follow-up.
AuthorsTiffany Rudloe, Sanjay P Prabhu, Mark P Gorman, Lise E Nigrovic, Marvin B Harper, Assaf Landschaft, Amir A Kimia
JournalJournal of child neurology (J Child Neurol) Vol. 30 Issue 10 Pg. 1333-9 (Sep 2015) ISSN: 1708-8283 [Electronic] United States
PMID25535060 (Publication Type: Journal Article)
Copyright© The Author(s) 2014.
Topics
  • Acute Disease
  • Adolescent
  • Age Factors
  • Ambulatory Care
  • Ataxia (diagnosis, pathology, therapy)
  • Brain (pathology)
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Emergency Service, Hospital
  • Female
  • Humans
  • Infant
  • Male
  • Neuroimaging
  • Risk
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: